Laborie Medical Technologies Corp ("Laborie") today announced the closing of the previously announced acquisition of the JADA® System, marking a major milestone in expanding the company's obstetrics ...
System for treatment of abnormal postpartum uterine bleeding, and the team behind the product, join Laborie, strengthening the company's commitment to improving maternal health. PORTSMOUTH, N.H., Jan.
More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...
For decades, hospitals have given babies a vitamin K injection to protect against bleeding. Now, the shot appears to be ...
News-Medical.Net on MSN
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
2don MSN
Synthetic protein potentially improves outcomes for select intracerebral hemorrhage patients
Results from the largest-ever clinical trial of its kind found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding ...
Researchers complete final analysis of a phase 3 study of men with hemophilia B receiving intravenous etranacogene dezaparvovec.
Mersana Therapeutics Inc.’s stock cratered on Thursday, after the U.S. Food and Drug Administration paused enrollment in two trials of a treatment for ovarian cancer after patients suffered bleeding ...
Periodontal disease is a common infection around the teeth, starting as gingivitis with red or bleeding gums. Symptoms can include bad breath, gum recession, and loose teeth. Treatment often starts ...
A new study of female U.S. service members has found that contracting COVID-19 can increase the risk of developing high blood pressure or hemorrhage during pregnancy but getting a COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results